Article

Risk of reactivation of hepatitis B virus (HBV) and tuberculosis (TB) and complications of hepatitis C virus (HCV) following Tocilizumab therapy: A systematic review to inform risk assessment in the COVID era

2021-03-26

Abstract excerpt

<h4>ABSTRACT</h4> Tocilizumab (TCZ), an IL-6 receptor antagonist, is used in the treatment of COVID. However, this agent carries a ‘black box’ warning for infection complications, which may include reactivation of tuberculosis (TB) or hepatitis B virus (HBV), or worsening of hepatitis C virus (HCV). Due to the pace of clinical research during the COVID pandemic, prospective evaluation of these risks has not been p...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 795834b6-eae9-5c25-bd82-1ae4bd0b8dcf
DOI: 10.1101/2021.03.22.21254128

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Risk of reactivation of hepatitis B virus (HBV) and tuberculosis (TB) and complications of hepatitis C virus (HCV) following Tocilizumab therapy: A systematic review to inform risk assessment in the COVID eraDOI 10.1101/2021.03.22.21254128Read

Incidence and associated risk factors of antituberculosis drug induced hepatotoxicity among TB patientsSemantic proximity Read

Risk of hepatitis B virus reactivation in B-cell malignancies treated with BTK inhibitorsSemantic proximity Read

Epidemiological Trends of Tuberculosis and HIV/Hepatitis Coinfections in Borno State, Nigeria from 2013 to 2024Semantic proximity Read

Assessment of Pharmacotherapy and Clinical Outcomes of Treatment for the Development of Cardiovascular Disease among Tuberculosis PatientsSemantic proximity Read

Tocilizumab for patients with COVID-19 pneumonia. The TOCIVID-19 prospective phase 2 trialSemantic proximity Read

Clinical and genetic markers associated with tuberculosis, HIV-1 infection, and TB/HIV-immune reconstitution inflammatory syndrome outcomes.Semantic proximity Read

Application of Tocilizumab in Drug-Induced Liver Injury: Pharmacovigilance Study Using the FAERS Database and the Drug-Gene Interaction Network AnalysisSemantic proximity Read

Molecular Epidemiology of Hepatitis C Virus and Resistance to Direct-Acting Antivirals in Tuberculosis Patients of Western Siberia (Tomsk region)Semantic proximity Read

Tocilizumab versus sarilumab among adults hospitalised with COVID-19: target trial emulation across England and ScotlandSemantic proximity Read

A systematic review and meta-analysis of Anakinra, Sarilumab, Siltuximab and Tocilizumab for Covid-19Semantic proximity Read

Contribution of post-TB sequelae to life-years and quality-adjusted life-years lost due to TB disease in the United States, 2015-2019Semantic proximity Read

Adverse events reported during weekly isoniazid-rifapentine (3HP) tuberculosis preventive treatment among people living with HIV in UgandaSemantic proximity Read